Scapho 150mg Secukinumab Injection Secukinumab 150mg Medicine Specification:- Brand Name : Scapho Injection Content : Secukinumab 150mg/ml Origin : India Packing : Pack of 1 vial Indications / Uses Moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. Active psoriatic arthritis, alone or in combination w/ methotrexate; when the response to previous disease-modifying anti-rheumatic drug therapy has been inadequate. Active ankylosing spondylitis in adults who have responded inadequately to conventional therapy. Dosage / Direction for Use Plaque psoriasis 300 mg by SC inj w/ initial dosing at wk 0, 1, 2 & 3 followed by mthly maintenance dosing starting at wk 4. Each 300 mg is given as 2 SC inj of 150 mg. Psoriatic arthritis 150 mg SC inj w/ initial dosing at wk 0, 1, 2 & 3, followed by mthly maintenance dosing starting at wk 4. Patients who are anti-TNFÎ± inadequate responders or w/ concomitant moderate to severe plaque psoriasis 300 mg by SC inj w/ initial dosing at wk 0, 1, 2 & 3, followed by mthly maintenance dosing starting at wk 4. Ankylosing spondylitis 150 mg by SC inj w/ initial dosing at wk 0, 1, 2 & 3, followed by mthly maintenance dosing starting at wk 4. Contraindications Hypersensitivity. Special Precautions Patients w/ chronic or history of recurrent infection; active Crohn's disease. Should not be given to patients w/ active TB; consider anti-TB therapy prior to initiation in patients w/ latent TB. Discontinue immediately & initiate appropriate therapy in rare case of anaphylactic or other serious allergic reactions. Not to be given concurrently w/ live vaccines. Pregnancy & lactation. Side Effects / Adverse Reactions Upper resp tract infections (eg, nasopharyngitis, rhinitis, pharyngitis, sinusitis, tonsillitis). Oral herpes, diarrhea, urticaria, rhinorrhea.
Valiant Organic is in the Chemicals sector. The current market capitalisation stands at Rs crore.
The company management includes Hemchand Lalji Gala - Chairman & Managing Director, Arvind Chheda - WholeTime Director & CFO, Vishnu Jotiram Sawant - Executive Director, Mahek Manoj Chheda - Executive Director, Chandrakant Valabhaji Gogri - Executive Director, Dattatray Sidram Galpalli - Non Executive Director, Dhirajlal Damji Gala - Independent Director, Jeenal Kenil Gala - Independent Director, Velji Gogri - Additional Director.
It is listed on the BSE with a BSE Code of 540145.
Its Registered office is at , Udyog Kshetra, 1st Floor,, Mulund Goregaon Link Road, Mumbai,Maharashtra - 400080.
Their Registrars are Bigshare Services Pvt. Ltd.